Efficacy of epidural steroid injection with hypertonic solution for post-herpetic neuralgia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002845

Enrollment

Registered

2018-05-04

Start date

2018-05-21

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Fluroscopy-guided epidural needle placement will be done. 1% lidcoaine 6cc will be infused first, and 3 minutes after the local anesthetic infusion, each group will be injected with 10% hyperto

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age > 18yrs 2) Patients complaining of neuralgia even after 4 months of onset of herpes zoster 3) Postherpetic neuralgia involving cervical, thoracic and lumbar spinal nerve. 4) Numerical rating scale (NRS) > 6 5) Patients with postherpetic neuralgia who are not responsive to oral or intravenous form of analgesics 6) Patients who spontaneously agreed to join the study by themselves.

Exclusion criteria

Exclusion criteria: 1) Patients who do not agreed to join the study. 2) Postherpetic neuralgia involving cranial and facial nerves. 3) Patients who had epidural steroid injection within 3 months prior to screening. 4) Pregnant or breast feeding patients. 5) Patients who are allergic to local anesthetics, contrast dye, steroid and hypertonic solution. 6) Patients with red flag signs (infection, cancer, coagulopathy, severe neurologic deficit, cauda equina syndrome) 7) Patients with uncontrolled medical or psychological diseases.

Design outcomes

Primary

Measure	Time frame
Numeric rating scale(NRS)	—

Secondary

Measure	Time frame
Insomnia Severity Index;, Global perceived effect 7-point scale,;current medication	—

Countries

Korea, Republic of

Contacts

Public ContactSeong-Soo Choi

Asan Medical Center

choiss@amc.seoul.kr+82-2-3010-1538

Outcome results